Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) vs HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Side-by-side comparison of two grants.
| Attribute | Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $100K |
| Deadline | Closes 2028-01-07 | Closes in 9 days |
| Region | US | US |
| Sector | Education | Education |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | researchers, students, government | researchers, students, government |